Protagonist Therapeutics (PTGX)

• Market cap: $8.79B
• 1 day: 0.95%
• 5 days: -3.58%
• 1 month: 11.92%
• 3 months: 36.71%
• 6 months: 66.11%
• Year to date: 56.81%
• 1 year: 154.39%
• 5 years: 192.12%
• 10 years: 1,068.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Employees: 131